Ignexto Biotex Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
- Revenue Growth -25.44%
- Profit Growth 41.74%
- Ebitda -484.57%
- Net Worth 163.03%
- Total Assets -95.30%
About Ignexto Biotex
Ignexto Biotex Private Limited (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and four months 10 days old ). Its registered office is in Gurugram, Haryana.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Ramachandran Subrahmaniam and Vishwa Pandey serve as directors at the Company.
Company Details
- LocationGurugram, Haryana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304HR2018PTC075917
- Company No.
075917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ignexto Biotex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramachandran Subrahmaniam  | Director | 01-Mar-2023 | Current |
| Vishwa Pandey | Director | 07-Jul-2022 | Current |
Financial Performance of Ignexto Biotex.
Ignexto Biotex Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.44% decrease. The company also saw a substantial improvement in profitability, with a 41.74% increase in profit. The company's net worth Soared by an impressive increase of 163.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ignexto Biotex?
In 2022, Ignexto Biotex had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Caristar Laboratories Private LimitedRamachandran Subrahmaniam is a mutual person
Evient Green Private LimitedVishwa Pandey is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2024 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Ignexto Biotex?
Ignexto Biotex has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ignexto Biotex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ignexto Biotex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
